a The refined population in SURPASS2 is the subgroup of participants who adhered to the inclusion criteria of HbA1c in SUSTAIN FORTE (8%10%)
When compared with Naltrexone/Bupropion, Tirzepatide users show lower rates of cataracts (HR 0.46, 95% CI 0.230.92, p = 0.025) and oculomotor dysfunction (HR 0.31, 95% CI 0.160.60, p = 2.3 10 4 )
Further studies have shown that Tirzepatide is generally well-tolerated with mild side effects that subside over time
Muscle is a prime metabolic driver, preserving our functional health and protecting against frailty as we age
At our firm, weve encountered various cases of semaglutide-induced vision loss, ranging from temporary issues to more severe, potentially permanent changes
Klinic's weight loss medications may be appropriate if you are an adult who is overweight or has obesity, particularly if you also have a weight-related health condition